MedPath

Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy

Not Applicable
Recruiting
Conditions
Oral Lichen Planus
Interventions
Drug: total glucosides of paeony treatment
Other: photodynamic therapy treatment
Other: glucosides of paeony and photodynamic therapy combined treatment
Registration Number
NCT05973097
Lead Sponsor
Peking University Third Hospital
Brief Summary

Oral lichen planus (OLP) is a common chronic inflammatory disease of the oral mucosa and is considered a precancerous condition. It is characterized by white reticular changes in the oral mucosa, which can progress to erosions and cause pain in severe cases. The pathogenesis of OLP is still unclear, but it is believed to be a T-lymphocyte-mediated autoimmune disease. Currently, only symptomatic treatments are available, and there is no definitive cure.

In this project, we plan to use TCM differentiation to categorize OLP patients and conduct a randomized controlled clinical trial to demonstrate the enhanced therapeutic effect of paeoniflorin combined with photodynamic therapy for OLP. The implementation of this project will provide new insights into the clinical management of OLP, improve our understanding of the treatment mechanisms, and have important theoretical and clinical implications.

Detailed Description

Paeoniflorin, a compound extracted from the traditional Chinese medicine, has anti-inflammatory and immunomodulatory effects. Photodynamic therapy is a novel local treatment approach, where photosensitizers selectively target and destroy diseased cells. Both treatments have shown efficacy in treating OLP when used individually.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
156
Inclusion Criteria
  • patients with oral lichen planus
  • male or female patients older than 18 years of age
  • patients willing to participate with signed informed consent.
Read More
Exclusion Criteria
  • pregnant or lactating
  • had serious systemic diseases of the heart, lung, liver, and kidney, or had tumors
  • were unwilling to participate in the experiment.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
total glucosides of paeony treatmenttotal glucosides of paeony treatmentTotal glucosides of paeony capsules were given 0.6 g once, 3 times a day.
photodynamic therapy treatmentphotodynamic therapy treatmentCover the lesion with photosensitizer and fix it. Remove the photosensitizer and treat with laser diode.
glucosides of paeony and photodynamic therapy combined treatmentglucosides of paeony and photodynamic therapy combined treatmentGlucosides of paeony and photodynamic therapy are combined for the treatment
Primary Outcome Measures
NameTimeMethod
Efficacy at 1 month of treatment1 month

According to the trial standard for evaluating the efficacy of atrophic and erosive oral lichen planus (OLP), the evaluation includes both objective and subjective measures.

Objective measure: The size of the lesion is measured by an observer. The physician records and takes photographs of the lesion, noting the location, color, and changes in the area. The color and area changes of the lesion are compared and determined based on the photographic records.

Subjective measure: Visual analogue scales (VAS) are used, which consist of 10 levels. The pain level is recorded, and the assessment is done by the patient.

Secondary Outcome Measures
NameTimeMethod
The curative effect at the later follow-up visitthrough study completion, an average of 1 year

According to the trial standard for evaluating the efficacy of atrophic and erosive oral lichen planus (OLP), the evaluation includes both objective and subjective measures.

Objective measure: The size of the lesion is measured by an observer. The physician records and takes photographs of the lesion, noting the location, color, and changes in the area. The color and area changes of the lesion are compared and determined based on the photographic records.

Subjective measure: Visual analogue scales (VAS) are used, which consist of 10 levels. The pain level is recorded, and the assessment is done by the patient.

Trial Locations

Locations (1)

Peking University Third Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath